IL95614A0 - Pharmaceutical compositions comprising an antibacterial compound and an absorption enhancing system - Google Patents

Pharmaceutical compositions comprising an antibacterial compound and an absorption enhancing system

Info

Publication number
IL95614A0
IL95614A0 IL95614A IL9561490A IL95614A0 IL 95614 A0 IL95614 A0 IL 95614A0 IL 95614 A IL95614 A IL 95614A IL 9561490 A IL9561490 A IL 9561490A IL 95614 A0 IL95614 A0 IL 95614A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
antibacterial compound
enhancing system
absorption enhancing
absorption
Prior art date
Application number
IL95614A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL95614A0 publication Critical patent/IL95614A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL95614A 1989-09-11 1990-09-07 Pharmaceutical compositions comprising an antibacterial compound and an absorption enhancing system IL95614A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40549489A 1989-09-11 1989-09-11

Publications (1)

Publication Number Publication Date
IL95614A0 true IL95614A0 (en) 1991-06-30

Family

ID=23603936

Family Applications (1)

Application Number Title Priority Date Filing Date
IL95614A IL95614A0 (en) 1989-09-11 1990-09-07 Pharmaceutical compositions comprising an antibacterial compound and an absorption enhancing system

Country Status (8)

Country Link
EP (1) EP0418674A1 (xx)
JP (1) JPH03106827A (xx)
AU (1) AU6236090A (xx)
CA (1) CA2024887A1 (xx)
HU (1) HU207216B (xx)
IE (1) IE903285A1 (xx)
IL (1) IL95614A0 (xx)
ZA (1) ZA906186B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5136105A (en) * 1991-03-28 1992-08-04 Union Carbide Chemicals & Plastics Technology Corporation Oxidation of terminal olefins to aldehydes
SI9400338A (en) * 1994-08-31 1996-04-30 Lek D D Vancomycin hydrochloride suspensions for peroral use and for filling into soft ,gelatine capsules.
GB9516268D0 (en) * 1995-08-08 1995-10-11 Danbiosyst Uk Compositiion for enhanced uptake of polar drugs from the colon
GB2318056B (en) * 1995-08-08 1999-05-26 Danbiosyst Uk Composition for enhanced uptake of polar drugs from the colon
JP2007042005A (ja) * 2005-08-05 2007-02-15 Toppan Forms Co Ltd メールアドレス収集方法、情報処理サーバおよびメールアドレス収集システム

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4525339A (en) * 1982-10-15 1985-06-25 Hoffmann-La Roche Inc. Enteric coated oral dosage form
EP0126348A2 (en) * 1983-05-19 1984-11-28 Kyoto Pharmaceutical Industries, Ltd. Composition for rectal administration and method of promoting rectal drug absorption
CA1256799A (en) * 1984-02-22 1989-07-04 Walter Fuller Suppositories

Also Published As

Publication number Publication date
CA2024887A1 (en) 1991-03-12
EP0418674A1 (de) 1991-03-27
JPH03106827A (ja) 1991-05-07
IE903285A1 (en) 1991-04-10
HUT56269A (en) 1991-08-28
ZA906186B (en) 1991-06-26
HU905823D0 (en) 1991-03-28
AU6236090A (en) 1991-03-14
HU207216B (en) 1993-03-29

Similar Documents

Publication Publication Date Title
GB9025491D0 (en) Pharmaceutical compositions
IL94821A0 (en) Monosaccharide compounds and pharmaceutical compositions containing the same
GB8904182D0 (en) Pharmaceutical compositions
GB8909022D0 (en) Pharmaceutical compositions
NZ233011A (en) Thieno-triazole-diazepine and pharmaceutical compositions
EP0409499A3 (en) Pharmaceutical compositions
IL95614A0 (en) Pharmaceutical compositions comprising an antibacterial compound and an absorption enhancing system
GB2232891B (en) Pharmaceutical composition
GB8909906D0 (en) Pharmaceutical compositions
ZA905512B (en) Pharmaceutical compositions
ZA905671B (en) Topical pharmaceutical compositions
NZ230703A (en) Substituted benzoxazolones and pharmaceutical compositions
ZA90476B (en) Pharmaceutical composition
GB8916657D0 (en) Pharmaceutical composition
IE890696L (en) Pharmaceutical composition
GB8907172D0 (en) Pharmaceutical composition
IE892553L (en) Pharmaceutical composition
GB8901235D0 (en) Pharmaceutical composition
GB8921274D0 (en) Pharmaceutical composition
GB8909692D0 (en) Pharmaceutical composition
GB8900952D0 (en) Pharmaceutical composition
GB8928855D0 (en) Pharmaceutical composition
GB8915044D0 (en) Pharmaceutical compositions
GB8919446D0 (en) Pharmaceutical compositions
GB8919447D0 (en) Pharmaceutical compositions